CN Patent

CN106061494A — 可用于治疗阿片样物质诱导的功能障碍的鸟苷酸环化酶的激动剂

Assigned to Doctor Medical Ireland Ltd · Expires 2016-10-26 · 10y expired

What this patent protects

本公开内容提供预防、控制和/或治疗阿片样物质诱导的功能障碍的方法，所述方法包括将鸟苷酸环化酶受体激动剂(GCRA)肽给予有需要的患者。还公开了包含鸟苷酸环化酶受体激动剂(GCRA)肽的组合物、制备方法和治疗方法。进一步公开了在同一组合物中配制的鸟苷酸环化酶受体激动剂(GCRA)肽和阿片样物质。

USPTO Abstract

本公开内容提供预防、控制和/或治疗阿片样物质诱导的功能障碍的方法，所述方法包括将鸟苷酸环化酶受体激动剂(GCRA)肽给予有需要的患者。还公开了包含鸟苷酸环化酶受体激动剂(GCRA)肽的组合物、制备方法和治疗方法。进一步公开了在同一组合物中配制的鸟苷酸环化酶受体激动剂(GCRA)肽和阿片样物质。

Drugs covered by this patent

chembl-chembl112 (ACETAMINOPHEN)

Patent Metadata

Patent number: CN106061494A
Jurisdiction: CN
Classification: —
Expires: 2016-10-26
Drug substance claim: No
Drug product claim: No
Assignee: Doctor Medical Ireland Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.